Institution Information
Reportee Signature Date Report period Total Entries Total AUM($)
FORESITE CAPITAL MANAGEMENT IV LLC 11-13-2019 09-30-2019 19 309,434,000
Institutional Holdings
Issuer Class Position Value Shares Portfolio Percentage (%) Previous Percentage (%) Shares Delta Shares Delta(%) Date Reported
Turning Point Therapeutics, Inc. COM 1 $68,672,000 1,826,374 22.19 21.06 -3,891 -0.21 09-30-2019
Aerie Pharmaceuticals, Inc. COM 2 $30,789,000 1,601,900 9.95 6.69 800,900 99.99 09-30-2019
Insmed Incorporated COM 3 $25,217,000 1,429,518 8.15 11.30 -131,667 -8.43 09-30-2019
The Medicines Company COM 4 $23,911,000 478,217 7.73 2.57 228,545 91.54 09-30-2019
Ascendis Pharma A/S SPONSORED ADR 5 $23,639,000 245,424 7.64 7.99 0 0.00 09-30-2019
Cytokinetics Incorporated COM NEW 6 $21,610,000 1,898,970 6.98 6.04 0 0.00 09-30-2019
Replimune Group, Inc. COM Liquidated $0 0 5.09 6.73 -1,000 -0.08 09-30-2019
Biohaven Pharmaceutical Holding Company Ltd. COM 8 $17,764,000 425,794 5.74 5.32 -3,896 -0.91 09-30-2019
OptiNose, Inc. COM 9 $15,666,000 2,238,006 5.06 5.05 -284,183 -11.27 09-30-2019
Voyager Therapeutics, Inc. COM 10 $14,294,000 830,565 4.62 4.13 293,794 54.73 09-30-2019
Alector, Inc. COM 11 $13,502,000 936,371 4.36 6.14 -207,091 -18.11 09-30-2019
Myokardia, Inc. COM 12 $12,421,000 238,186 4.01 3.65 -19,266 -7.48 09-30-2019
Fulcrum Therapeutics, Inc. COM 13 $11,205,000 1,687,500 3.62 1,687,500 +Inf 09-30-2019
CymaBay Therapeutics, Inc. COM 14 $10,549,000 2,060,268 3.41 5.20 -510,990 -19.87 09-30-2019
NGM Biopharmaceuticals, Inc. COM Liquidated $0 0 1.95 471,269 +Inf 09-30-2019
Orchard Therapeutics PLC ADS 16 $6,625,000 557,700 2.14 557,700 +Inf 09-30-2019
Veracyte, Inc. COM Liquidated $0 0 1.61 200,000 +Inf 09-30-2019
Rhythm Pharmaceuticals, Inc. COM 18 $5,062,000 234,482 1.64 2.92 -235,000 -50.06 09-30-2019
Immunomedics, Inc. COM 19 $4,875,000 367,636 1.58 1.51 -18,115 -4.70 09-30-2019
SI-BONE, Inc. COM 20 $3,633,000 205,621 1.17 1.18 0 0.00 09-30-2019
Arbutus Biopharma Corporation COM Liquidated $0 0 0.36 1.04 -196,295 -24.40 09-30-2019
Kiniksa Pharmaceuticals, Ltd. Class A Common Liquidated $0 0 0.24 0.41 0 0.00 09-30-2019
Debug Info- Version: 2.1